TEAS RF New Application

BREYANZI

JUNO THERAPEUTICS, INC.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88569196
Filing Date: 08/07/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88569196
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\885\691\88569196\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT BREYANZI
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 1382 x 603
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Celgene Corporation
*STREET 86 Morris Avenue
*CITY Summit
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
07901
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 5709663.
ATTORNEY INFORMATION
NAME Camille M. Miller
ATTORNEY DOCKET NUMBER 453618/CELG-
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS One Liberty Place
STREET 1650 Market Street, Suite 2800
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19103
PHONE 215-665-7273
FAX 215-701-7273
EMAIL ADDRESS cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Melanie Miller; J. Trevor Cloak; Chanel Lattimer; Brianne Polito; Ashley Kessley, Mayura Noordyke; Kevin Gibbs
CORRESPONDENCE INFORMATION
NAME Camille M. Miller
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS One Liberty Place
STREET 1650 Market Street, Suite 2800
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19103
PHONE 215-665-7273
FAX 215-701-7273
*EMAIL ADDRESS cmiller@cozen.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Camille M. Miller/
SIGNATORY'S NAME Camille M. Miller
SIGNATORY'S POSITION Attorney
SIGNATORY'S PHONE NUMBER 215-665-7273
DATE SIGNED 08/07/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88569196
Filing Date: 08/07/2019

To the Commissioner for Trademarks:

MARK: BREYANZI (stylized and/or with design, see mark)
The literal element of the mark consists of BREYANZI. The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark. The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
The applicant, Celgene Corporation, a corporation of Delaware, having an address of
      86 Morris Avenue
      Summit, New Jersey 07901
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5709663.


The applicant hereby appoints Camille M. Miller. Other appointed attorneys are Melanie Miller; J. Trevor Cloak; Chanel Lattimer; Brianne Polito; Ashley Kessley, Mayura Noordyke; Kevin Gibbs. Camille M. Miller of Cozen O'Connor, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      One Liberty Place
      1650 Market Street, Suite 2800
      Philadelphia, Pennsylvania 19103
      United States
      215-665-7273(phone)
      215-701-7273(fax)
      cmiller@cozen.com (authorized).
The attorney docket/reference number is 453618/CELG-.
Camille M. Miller submitted the following statement: I attest that I am an attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory).

The applicant's current Correspondence Information:
      Camille M. Miller
      Cozen O'Connor
      One Liberty Place
      1650 Market Street, Suite 2800
      Philadelphia, Pennsylvania 19103
      215-665-7273(phone)
      215-701-7273(fax)
      cmiller@cozen.com (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Camille M. Miller/   Date: 08/07/2019
Signatory's Name: Camille M. Miller
Signatory's Position: Attorney
Payment Sale Number: 88569196
Payment Accounting Date: 08/07/2019

Serial Number: 88569196
Internet Transmission Date: Wed Aug 07 07:28:36 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2019080707283630
9808-88569196-610191f6edfcd4f9a2217398cc
9bfa38985a3b4b60a5f3971699bfa4268377fb9-
CC-28351094-20190807071521421697

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed